NCT01940133View on ClinicalTrials.gov

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

December 31, 2015

Conditions
Advanced Solid Tumors
Interventions
DRUG

PQR309

Dosing will be orally, once a day for the duration of the trial.

Trial Locations (1)

4031

University Hospital Basel, Basel

Sponsors
All Listed Sponsors
lead

PIQUR Therapeutics AG

INDUSTRY

NCT01940133 - A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309 | Biotech Hunter | Biotech Hunter